INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹23 Cr | ₹-44 Cr | ₹-30 Cr | ₹-64 Cr | ₹-16 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹23 Cr |
Mar2022 | ₹-44 Cr |
Mar2021 | ₹-30 Cr |
Mar2020 | ₹-64 Cr |
Mar2019 | ₹-16 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹23 Cr | Positive | |
Mar2022 | ₹-44 Cr | Negative | |
Mar2021 | ₹-30 Cr | Negative | |
Mar2020 | ₹-64 Cr | Negative | |
Mar2019 | ₹-16 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,110.8 Cr | 2.7% | -0.6% | 2.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 2.7% |
-0.6% |
2.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses